Search research articles
Contact Us
Filters
Showing results (121-130 of 161) with videos related to
Page
of 17
Sort By:
Molecular Oncology
|
August 26, 2021
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial
Mariaelena Pierobon, Nicholas J Robert, Donald W Northfelt, et al.
Investigational New Drugs
|
September 29, 2018
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases
Hani M Babiker, Sara A Byron, William P D Hendricks, et al.
Pancreas
|
February 25, 2025
Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients
Andrea N Riner, Enrique I Velazquez-Villarreal, Seeta Rajpara, et al.
American Journal of Human Genetics
|
December 13, 2006
Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies
John V Pearson, Matthew J Huentelman, Rebecca F Halperin, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Cells
|
July 6, 2023
Genetic and Protein Network Underlying the Convergence of Rett-Syndrome-like (RTT-L) Phenotype in Neurodevelopmental Disorders
Eric Frankel, Avijit Podder, Megan Sharifi, et al.
Neuro-Oncology
|
May 3, 2015
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D Prados, Sara A Byron, Nhan L Tran, et al.
Oncogene
|
August 26, 2021
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients
M Kathryn Leonard, Gemma S Puts, Nidhi Pamidimukkala, et al.
The New England Journal of Medicine
|
January 13, 2012
Germline mutations in HOXB13 and prostate-cancer risk
Charles M Ewing, Anna M Ray, Ethan M Lange, et al.
Oncogene
|
October 12, 2021
Correction: Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients
M Kathryn Leonard, Gemma S Puts, Nidhi Pamidimukkala, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 161) with videos related to
Sort By:
Page
of 17
Molecular Oncology
|
August 26, 2021
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial
Mariaelena Pierobon, Nicholas J Robert, Donald W Northfelt, et al.
Investigational New Drugs
|
September 29, 2018
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases
Hani M Babiker, Sara A Byron, William P D Hendricks, et al.
Pancreas
|
February 25, 2025
Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients
Andrea N Riner, Enrique I Velazquez-Villarreal, Seeta Rajpara, et al.
American Journal of Human Genetics
|
December 13, 2006
Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies
John V Pearson, Matthew J Huentelman, Rebecca F Halperin, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Cells
|
July 6, 2023
Genetic and Protein Network Underlying the Convergence of Rett-Syndrome-like (RTT-L) Phenotype in Neurodevelopmental Disorders
Eric Frankel, Avijit Podder, Megan Sharifi, et al.
Neuro-Oncology
|
May 3, 2015
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D Prados, Sara A Byron, Nhan L Tran, et al.
Oncogene
|
August 26, 2021
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients
M Kathryn Leonard, Gemma S Puts, Nidhi Pamidimukkala, et al.
The New England Journal of Medicine
|
January 13, 2012
Germline mutations in HOXB13 and prostate-cancer risk
Charles M Ewing, Anna M Ray, Ethan M Lange, et al.
Oncogene
|
October 12, 2021
Correction: Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients
M Kathryn Leonard, Gemma S Puts, Nidhi Pamidimukkala, et al.
Page
of 17